<SEC-DOCUMENT>0001104659-18-046840-index.html : 20180725 <SEC-HEADER>0001104659-18-046840.hdr.sgml : 20180725 <ACCEPTANCE-DATETIME>20180725085451 ACCESSION NUMBER: 0001104659-18-046840 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180725 DATE AS OF CHANGE: 20180725 EFFECTIVENESS DATE: 20180725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 18967766 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>DEFA14A <SEQUENCE>1 <FILENAME>a18-17513_2defa14a.htm <DESCRIPTION>DEFA14A <TEXT> Document 1 - file: a18-17513_2defa14a.htm
</DOCUMENT> </SEC-DOCUMENT>